Hormone Therapy Management Visits — Initiation, Monitoring, and Adjustment Over Time
Starting hormone therapy is a decision — but managing it well is an ongoing process. The right formulation, dose, and delivery method are rarely identified at the first visit. Symptom response, lab values, and tolerance guide adjustments over the first several months. Then, once stable, annual monitoring ensures the therapy continues to serve its purpose without unnecessary risk accumulation.
At Lapeer Women’s Health, hormone therapy management visits are structured follow-up appointments specifically designed to evaluate how your therapy is working — not a brief check-in that results in an automatic refill. Dr. Andrei reviews your symptom picture, your most recent lab results, your current formulation and dose, and any concerns or side effects you have noticed since your last visit. Every adjustment is explained and documented.
Hormone therapy management at LWH covers systemic estrogen and progesterone for menopausal symptoms, testosterone for libido and energy in appropriate patients, DHEA, and the full range of delivery methods — oral, transdermal patch, gel, spray, vaginal ring, and pellet therapy discussion. Dr. Andrei does not prescribe hormone therapy without a plan for monitoring it.
Hormone Therapy Visit Structure — What Dr. Andrei Reviews
Each hormone therapy management visit follows a structured review. These are the components addressed at every follow-up appointment.
Symptom reassessment
Hot flash frequency and severity, sleep quality, vaginal symptoms, mood, energy, libido, and joint pain — all reassessed systematically at each visit to determine whether the current therapy is providing adequate relief or whether dose adjustment is indicated.
Lab result review
Hormone levels — estradiol, progesterone, total and free testosterone, SHBG — reviewed in the context of symptom response. Dr. Andrei interprets lab values alongside clinical picture, not as standalone numbers. A hormone level in the “normal range” that is not producing symptom relief requires clinical discussion, not automatic acceptance.
Dose and formulation adjustment
Estrogen dose is titrated based on symptom response and lab values. Progesterone formulation may be adjusted for tolerance. Testosterone dosing is refined based on lab values and symptom response. Delivery method changes — patch to gel, oral to transdermal — are discussed when absorption or tolerance is suboptimal.
Side effect and tolerance review
Breakthrough bleeding, breast tenderness, fluid retention, skin irritation at patch sites, and mood changes are common adjustment-phase issues. Dr. Andrei distinguishes expected early side effects from those requiring formulation change and addresses tolerance concerns at every visit.
Benefit-risk reassessment
The benefit-risk calculation for hormone therapy is not static — it changes as a patient ages and as new health information emerges. Dr. Andrei reviews the ongoing appropriateness of hormone therapy at each annual visit and discusses any changes in cardiovascular, breast, or bone health status that affect the calculus.
Metabolic and safety monitoring
Blood pressure, lipid panel, liver function, and complete metabolic panel reviewed at appropriate intervals. Some oral estrogen formulations affect lipid metabolism and clotting factors differently than transdermal formulations — monitoring protocol is tailored to the specific therapy and route of administration.
Delivery Methods — Which Formulation and Why It Matters
Hormone therapy is not one product — it is a category with dozens of formulations, doses, and delivery routes. The choice between them affects absorption, side effect profile, metabolic impact, and patient preference. Dr. Andrei explains the rationale behind every formulation decision.
- Oral estrogen — convenient, well-studied; first-pass liver metabolism increases clotting factor and triglyceride production compared to transdermal
- Transdermal patch — bypasses liver metabolism; preferred for patients with clotting risk, hypertriglyceridemia, or migraine; twice-weekly or weekly depending on formulation
- Estrogen gel or spray — daily transdermal application; useful for patients with patch adhesion issues or skin sensitivity
- Vaginal ring (Femring) — systemic estrogen delivered vaginally; changed every 3 months; not the same as local vaginal estrogen rings
- Progesterone — oral micronized progesterone (Prometrium) preferred over synthetic progestins for most patients; available as vaginal suppository for those with oral intolerance
- Testosterone — compounded topical cream or gel; off-label in women but supported by evidence for libido and energy; monitored by lab values
“Hormone therapy management is where the real work of menopause care happens — not at the first prescription, but at every follow-up visit where we assess whether the therapy is actually doing what we want it to do and whether the dose and formulation still make sense for this patient at this stage of her life.”
- Initial follow-up at 6–12 weeks after starting therapy to assess early response
- Lab draw at 3 months to check hormone levels and metabolic markers
- Visits every 3–6 months during the titration phase
- Annual visit once stable — symptom review, benefit-risk reassessment, lab panel
- Telehealth available for follow-up visits and result reviews at Rochester Hills on Mondays
- Prescriptions managed at LWH — no fragmented care between prescribing and monitoring
Questions About Hormone Therapy Management
Hormone Therapy That
Is Actually Managed.
Structured hormone therapy management with Dr. Andrei — initiation, titration, lab monitoring, and ongoing adjustment. A prescription without a monitoring plan is not hormone therapy management.
The information on this page is intended for educational purposes only and does not constitute medical advice. Individual symptoms, diagnoses, and treatment options vary significantly. Reading this content does not establish a physician-patient relationship with Dr. Ramona D. Andrei or Lapeer Women’s Health. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately. Please consult a qualified healthcare provider for advice specific to your situation. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.